Clinical trials: Young
Waterpipe Tobacco Smoking
A Study of Hookah Café Customers in the Atlanta Area
The purpose of the study is to assess the effectiveness of health warnings on waterpipe smoking behavior in a real-world setting.
- Trial name
- NCT05916170
- Testing
- Health Warnings, No Warnings
- Where
- United States
- Volunteers
- 977 people, healthy volunteers welcome
- Sponsor
- Wake Forest University Health Sciences
Tobacco-Related Carcinoma
Evaluating Anti-Tobacco Message Effectiveness Among Lesbian, Gay, Bisexual, and Transgender Young Adults
This trial refines and evaluates anti-tobacco messages among lesbian, gay, bisexual, and transgender (LGBT) young adults at risk for the use of more than one tobacco product (polytobacco use).
- Trial name
- NCT05393869
- Testing
- Health communications
- Where
- United States
- Volunteers
- 2,849 people, healthy volunteers welcome
- Sponsor
- Ohio State University Comprehensive Cancer Center
Pneumococcal Infections
A Study To Assess The Safety And Effectiveness Of Prevenar In Chinese Children Who Have Not Previously Received A Vaccine Against Pneumococcal Bacteria
A vaccine called Prevenar is already approved for use in China for vaccination of children younger than 6 years old against infections caused by Streptococcus pneumoniae.
- Trial name
- 6114A1-4000-CN (NCT01193582)
- Testing
- Prevenar
- Where
- 5 sites in China
- Volunteers
- 505 people, healthy volunteers welcome
- Sponsor
- Pfizer
Quadriceps Muscle
Effect of Antibacterial Mouthwash on Muscle Function in Healthy Young Men and Women
The purpose of this study is to determine the effects of antibacterial mouthwash on muscle speed and power in healthy young men and women.
- Trial name
- NCT04095442
- Testing
- Cepacol, Tom's Natural Mouthwash
- Where
- United States
- Volunteers
- 32 people, healthy volunteers welcome
- Sponsor
- Indiana University
Cigar Smoking
The Impact of Cigarillo Warnings on Purchasing
The purpose of this study is to determine whether different cigarillo warning formats (pictorial, FDA-proposed text-only, current Surgeon General text-only) reduces demand for cigarillos.
- Trial name
- NCT05434013
- Testing
- Cigarillo warnings-Surgeon General Text-Only, Cigarillo warnings-FDA proposed text-only, Cigarillo warnings-Pictorial
- Where
- United States
- Volunteers
- 1,578 people, healthy volunteers welcome
- Sponsor
- Boston University
Autism Spectrum Disorder, Autistic Disorder
Sulforaphane for the Treatment of Young Men With Autism Spectrum Disorder
The aim of this randomized controlled trial is to determine if a nutritional supplement containing broccoli sprout and seed extracts, a rich source of sulforaphane, is effective in reducing core symptoms of autism spectrum…
- Conditions
- Autism Spectrum Disorder, Autistic Disorder, Neurodevelopmental Disorder, Childhood Developmental Disorders, Pervasive
- Trial name
- NCT02909959
- Testing
- Sulforaphane
- Where
- United States
- Volunteers
- 48 people
- Sponsor
- University of North Carolina, Chapel Hill
Hepatitis C, Drug Use
HCV Seek, Test and Rapid Treatment for Young PWID
The purpose of this randomized study is to determine whether a community-based test and treat model of hepatitis C (HCV) care delivery will be superior to the usual care practice of referral to specialist clinics for the outcomes…
- Trial name
- HCV ST&RT (NCT03627546)
- Testing
- Rapid Treatment strategy, Usual Care (facilitated referral)
- Where
- United States
- Volunteers
- 39 people
- Sponsor
- Weill Medical College of Cornell University
Ependymoma, Ewing Sarcoma
A Study of Bempegaldesleukin (BEMPEG: NKTR-214) in Combination With Nivolumab in Children, Adolescents and Young Adults With Recurrent or Treatment-resistant Cancer
The purpose of this study is to first, in Part A, assess the safety, tolerability and drug levels of Bempegaldesleukin (BEMPEG) in combination with nivolumab and then, in Part B, to estimate the preliminary efficacy in children…
- Conditions
- Ependymoma, Ewing Sarcoma, High-grade Glioma, Leukemia and Lymphoma
- Trial name
- PIVOT IO 020 (NCT04730349)
- Testing
- Nivolumab, NKTR-214
- Where
- 18 sites in United States, Australia and 4 more
- Volunteers
- 15 people
- Sponsor
- Bristol-Myers Squibb